CAM
RYZB

Cormorant Asset Management’s RayzeBio, Inc. Common Stock RYZB Stock Holding History

Cormorant Asset Management’s Portfolio RYZB Stock Details RYZB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,213,478
Closed -$75.4M – 66
2023
Q4 		$75.4M Buy
1,213,478
+31,215
+3% +$776K 3.6% 6
2023
Q3 		$26.2M Buy
+1,182,263
New +$24.8M 1.53% 17

Cormorant Asset Management's RYZB Position: Q1 2024 in Review

Cormorant Asset Management sold out of RayzeBio, Inc. Common Stock (RYZB) in Q1 2024, closing a stake of 1,213,478 shares — an estimated $75.4M sold.

Cormorant Asset Management first reported a position in RYZB in Q3 2023 and held it in 2 quarters. The position peaked at $75.4M in Q4 2023. 0 funds tracked by Wall St. Rank hold RYZB as of Q1 2024.

  • Cormorant Asset Management reported no remaining RayzeBio, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Cormorant Asset Management sold 1,213,478 RayzeBio, Inc. Common Stock shares in Q1 2024, an estimated $75.4M.
  • Cormorant Asset Management first reported a position in RayzeBio, Inc. Common Stock in Q3 2023 and held it in 2 quarters.
  • Cormorant Asset Management's RayzeBio, Inc. Common Stock position peaked at $75.4M in Q4 2023.
  • 0 funds tracked by Wall St. Rank held RayzeBio, Inc. Common Stock as of Q1 2024.

Based on Cormorant Asset Management's 13F filing for Q1 2024, filed 15 May 2024.